The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome.

Robert KrysiakWitold SzkróbkaBogusław Okopień

Published in: Pharmacological reports : PR (2020)

The obtained results suggest that cardiometabolic effects of atorvastatin are less pronounced in male siblings of PCOS probands than in brothers of unaffected women.

Keyphrases

polycystic ovary syndrome
risk factors
pregnancy outcomes
insulin resistance
cervical cancer screening
breast cancer risk
type diabetes
adipose tissue
pregnant women
skeletal muscle